Alkem Strengthens Ujjain Expansion with Rs 1,036 Crore Investment

Alkem Strengthens Ujjain Expansion as Alkem Laboratories on Thursday announced it will nearly double its investment to Rs 1,036 crore for a greenfield formulations manufacturing facility in Ujjain, Madhya Pradesh.

The move highlights how Alkem Strengthens Ujjain Expansion through a phased capex plan aimed at boosting production capacity and supporting future growth.

The company said its board of directors, in a meeting held on April 2, approved increasing the investment from the earlier planned Rs 533 crore to Rs 1,036 crore. The spending will be carried out in phases for setting up the formulations manufacturing unit in Ujjain.

Also Read: Advancing Interventional Radiology in India Through Collaboration

This development comes shortly after the company secured land for the project. On March 18, Alkem Laboratories confirmed it received an allotment letter from DMIC Vikram Udyogpuri Ltd for 30 acres in Ujjain, where the greenfield facility will be developed.

With the revised plan, the Alkem Laboratories investment signals a stronger commitment to scaling operations and meeting rising demand in the pharmaceutical sector. The phased investment approach is expected to help the company manage capital efficiently while building long-term manufacturing capabilities.

The Ujjain facility will play a key role in boosting domestic production and supporting future growth. The expansion aligns with broader industry trends where pharmaceutical companies are increasing investments in India to enhance supply chains and reduce dependency on external sources.